Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDC14B | O60729 | 3/20 | 0.49 |
| ▸ | CDC14A | Q9UNH5 | 3/20 | 0.49 |
| ▸ | MAOA | P21397 | 4/20 | 0.44 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | GLA | P06280 | 2/20 | 0.41 |
| ▸ | PGAM1 | P18669 | 2/20 | 0.41 |
| ▸ | HPGD | P15428 | 2/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | CASP1 | P29466 | 1/20 | 0.41 |
| ▸ | CASP7 | P55210 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | CCR2 | P41597 | 1/20 | 0.40 |
| ▸ | AHR | P35869 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4907475 | 0.79 | CA1 (0.55) | CDC14BCDC14AMAOAHDAC1ALDH1A1 | |
| SCHEMBL329795 | 0.79 | ALDH1A1 (0.47) | CDC14BCDC14AMAOAHDAC1ALDH1A1 | |
| SCHEMBL29945034 | 0.77 | MAOA (0.47) | CDC14BCDC14AMAOAHDAC1ALDH1A1 | |
| SCHEMBL329796 | 0.77 | MAOA (0.47) | CDC14BCDC14AMAOAHDAC1ALDH1A1 | |
| SCHEMBL6987366 | 0.77 | MAOA (0.45) | CDC14BCDC14AMAOAHDAC1ALDH1A1 | |
| SCHEMBL17847526 | 0.75 | NQO1 (0.50) | MAOAALDH1A1GLAPGAM1HPGD | |
| SCHEMBL6929900 | 0.73 | CA2 (0.44) | ALDH1A1SMN1; SMN2CCR2GAAHTT | |
| SCHEMBL18795081 | 0.73 | CDC14B (0.46) | CDC14BCDC14AMAOAALDH1A1GLA | |
| SCHEMBL3241709 | 0.73 | CA1 (0.57) | MAOAALDH1A1CYP3A4KDM4EHSD17B10 | |
| Dibenzofuran SCHEMBL21611805 | 0.73 | MAOA (0.48) | CDC14BCDC14AMAOAALDH1A1GLA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12035625-B2 | Materials for organic electroluminescent devices | MERCK PATENT GMBH (DE) | 2024-07-09 | — | — | US | disclosed |
| US-12035625-B2 | Materials for organic electroluminescent devices | MERCK PATENT GMBH (DE) | 2024-07-09 | — | — | US | disclosed |
| EP-3880682-B1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2023-06-14 | — | — | EP | disclosed |
| CN-114478562-A | Compound and application thereof | 上海和辉光电股份有限公司 | 2022-05-13 | — | — | CN | disclosed |
| US-20220006030-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2022-01-06 | — | — | US | disclosed |
| WO-2020099307-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2020-05-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220006030-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | ZYX, RER1, AOC2 | CDC14B 4657/4885CDC14A 4602/4885MAOA 1223/4885 |
| US-12035625-B2 | Materials for organic electroluminescent devices | ZYX, RER1, AOC2 | CDC14B 4657/4885CDC14A 4602/4885MAOA 1223/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.